Mode
Text Size
Log in / Sign up

FRMPD4 gene variants associated with prelingual hearing loss in two families, cross-species studies showGenetic study links FRMPD4 gene variants to early-onset hearing loss in families

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider FRMPD4 in genetic panels for congenital hearing loss, but recognize evidence is from a small familial association.

This study combined human genetic analysis with cross-species functional characterization. Researchers identified maternally inherited missense variants in the FRMPD4 gene in three affected males from two unrelated families with non-syndromic sensorineural hearing loss. The human phenotype was characterized as prelingual, bilaterally symmetrical hearing loss, with congenital onset confirmed in one individual. No neurodevelopmental abnormalities were reported in these cases.

Functional studies were conducted across multiple species. In Drosophila, FRMPD4 homolog mutants showed impaired auditory function. In zebrafish, FRMPD4 knockdown led to reduced neuronal populations in the otic vesicle and posterior lateral line, abnormal neuromast development, and diminished acoustic startle responses. In mice, Frmpd4 knockout resulted in high-frequency hearing loss and cochlear abnormalities.

Safety and tolerability data were not reported for the human subjects. The study's key limitations include a very small human sample size of only three affected males from two families. The findings, while providing strong cross-species evidence for FRMPD4's role in auditory function, demonstrate an association rather than definitive proof of causation in humans. The practice relevance lies in potentially expanding the genetic diagnostic panel for patients with congenital hearing loss, but clinical application requires validation in larger cohorts.

Scientists investigated whether changes in a gene called FRMPD4 might be connected to hearing loss. They studied three males from two unrelated families who had hearing loss from birth or early childhood. All three carried inherited variants in this gene, and none showed other neurological or developmental issues.

To understand how FRMPD4 might work, the team studied the gene in fruit flies, zebrafish, and mice. They found that disrupting this gene led to hearing problems or abnormal ear development in all these animals. This suggests FRMPD4 has an important and conserved role in hearing across different species.

It's important to be cautious about these results. The human part of the study involved only three people from two families, which is a very small sample. The findings in animals, while helpful for understanding biology, do not directly prove how the gene works in people. No safety concerns were reported, as this was not a treatment study.

For now, this research helps scientists better understand the genetic causes of hearing loss. It may eventually help with genetic diagnosis for families, but much more research in larger human populations is needed first.

What this means for you:
Early research links a gene to hearing loss in a few families, but more evidence is needed.

Study Details

EvidenceLevel 5
PublishedMar 2026
View Original Abstract ↓
BackgroundUnderstanding the phenotypic spectrum of disease-associated genes is essential for accurate diagnosis and targeted therapy. FRMPD4 (FERM and PDZ Domain Containing 4) has previously been associated with intellectual disability and epilepsy. However, its potential role in non-syndromic hearing loss has not been explored. MethodsWe performed genetic analysis in two unrelated families presenting with non-syndromic sensorineural hearing loss, identifying maternally inherited missense variants in FRMPD4. Clinical phenotyping included audiological assessment and evaluation for neurodevelopmental involvement. Cross-species expression analyses were conducted in Drosophila, zebrafish, and mouse. Functional characterization included quantitative evaluation of sound-evoked responses in Drosophila nicht gut horend (ngh) mutants, assessment of neuronal development and acoustic startle responses in zebrafish loss of function models, and morphological cochlear analyses with auditory brainstem response measurements in knockout mice. ResultsThree affected males from two unrelated families presented with prelingual, bilaterally symmetrical sensorineural hearing loss, with confirmed congenital onset in one individual and no evidence of neurodevelopmental abnormalities. Cross-species analyses demonstrated evolutionarily conserved expression of FRMPD4 in auditory structures. In Drosophila, quantitative analysis of sound-evoked responses in ngh mutants revealed impaired auditory function. Zebrafish loss of function models exhibited reduced neuronal populations in the otic vesicle and posterior lateral line, abnormal neuromast development, and diminished acoustic startle responses. In mice, Frmpd4 knockout resulted in high-frequency hearing loss and cochlear abnormalities consistent with the human phenotype. ConclusionsOur findings expand the phenotypic spectrum of FRMPD4 to include non-syndromic sensorineural hearing loss and establish its evolutionarily conserved role in auditory function. These results have direct implications for genetic diagnosis and variant interpretation in patients with hearing loss.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.